| Association of obesity-related metabolic disruptions with cancer risk and outcome AE Lohmann, PJ Goodwin, RT Chlebowski, K Pan, V Stambolic, ... Journal of Clinical Oncology 34 (35), 4249-4255, 2016 | 95 | 2016 |
| A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy I Pimentel, AE Lohmann, M Ennis, RJO Dowling, D Cescon, C Elser, ... The Breast 48, 17-23, 2019 | 89 | 2019 |
| Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis AE Lohmann, SV Soldera, I Pimentel, D Ribnikar, M Ennis, E Amir, ... JNCI: Journal of the National Cancer Institute 113 (11), 1465-1475, 2021 | 66 | 2021 |
| Sexual health in long-term breast cancer survivors SV Soldera, M Ennis, AE Lohmann, PJ Goodwin Breast Cancer Research and Treatment 172, 159-166, 2018 | 43 | 2018 |
| The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA. 32 I Pimentel, BE Chen, AE Lohmann, M Ennis, J Ligibel, L Shepherd, ... JNCI: Journal of the National Cancer Institute 113 (2), 192-198, 2021 | 29 | 2021 |
| Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA. 21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer AE Lohmann, JAW Chapman, MJ Burnell, MN Levine, E Tsvetkova, ... Breast Cancer Research and Treatment 150, 605-611, 2015 | 23 | 2015 |
| Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls AE Lohmann, M Ennis, SK Taylor, PJ Goodwin Breast Cancer Research and Treatment 164, 451-460, 2017 | 21 | 2017 |
| Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it? AE Lohmann, S Chia Current treatment options in oncology 13, 249-262, 2012 | 20 | 2012 |
| Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: a nationwide clinical study A Di Meglio, S Michiels, LW Jones, M El-Mouhebb, AR Ferreira, E Martin, ... The Breast 52, 23-32, 2020 | 19 | 2020 |
| Toronto workshop on late recurrence in estrogen receptor–positive breast cancer: part 1: late recurrence: current understanding, clinical considerations RJO Dowling, K Kalinsky, DF Hayes, FC Bidard, DW Cescon, ... JNCI Cancer Spectrum 3 (4), pkz050, 2019 | 19 | 2019 |
| Association of metabolic, inflammatory, and tumor markers with circulating tumor cells in metastatic breast cancer AE Lohmann, RJO Dowling, M Ennis, E Amir, C Elser, C Brezden-Masley, ... JNCI Cancer Spectrum 2 (2), pky028, 2018 | 18 | 2018 |
| Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia AE Lohmann, CH Speers, SK Chia Current Oncology 20 (2), 97-103, 2013 | 17 | 2013 |
| Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA. 32 AE Lohmann, MF Liebman, W Brien, WR Parulekar, KA Gelmon, ... Breast cancer research and treatment 164, 371-378, 2017 | 15 | 2017 |
| Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications V Bhat, S Pellizzari, AL Allan, E Wong, M Lock, M Brackstone, ... Critical Reviews in Oncology/Hematology 169, 103566, 2022 | 14 | 2022 |
| Toronto workshop on late recurrence in estrogen receptor-positive breast cancer: part 2: approaches to predict and identify late recurrence, research directions RJO Dowling, JA Sparano, PJ Goodwin, FC Bidard, DW Cescon, ... JNCI Cancer Spectrum 3 (4), pkz049, 2019 | 13 | 2019 |
| Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges UA Shah, TJ Ballinger, R Bhandari, CM Dieli-Conwright, KA Guertin, ... JNCI Monographs 2023 (61), 56-67, 2023 | 9 | 2023 |
| Normal weight adiposity and postmenopausal breast cancer risk I Pimentel, AE Lohmann, PJ Goodwin JAMA oncology 5 (2), 150-151, 2019 | 9 | 2019 |
| Antibody–drug conjugates in breast cancer: Ascent to destiny and beyond—A 2023 review T Xiao, S Ali, DGMM Mata, AE Lohmann, PS Blanchette Current Oncology 30 (7), 6447-6461, 2023 | 7 | 2023 |
| Obesity and breast cancer: expanding the hypothesis space AE Lohmann, PJ Goodwin JNCI: Journal of the National Cancer Institute 113 (2), 107-108, 2021 | 6 | 2021 |
| Prognostic associations of plasma hepcidin in women with early breast cancer KJ Jerzak, AE Lohmann, M Ennis, E Nemeth, T Ganz, PJ Goodwin Breast cancer research and treatment 184, 927-935, 2020 | 6 | 2020 |
